DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 41.05
0.00 (0.00%)
Sep 8, 2026, 1:17 PM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 999.53 million as of September 4, 2026. Its market cap has decreased by -26.70% in one year.
Market Cap
999.53M
Enterprise Value
683.62M
Revenue
795.19M
Ranking
n/a
PE Ratio
12.99
Stock Price
41.05
ChartMarket Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 999.53M, a decrease of -80.04%. That is a compound annual growth rate of -13.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 999.53M | -30.42% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merdury Biopharmaceutical | 2.16B |
| TSH Biopharm Corporation | 1.93B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.15B |
| Prince Pharmaceutical | 1.06B |
| Anxo Pharmaceutical | 969.47M |
| Winston Medical Supply | 812.19M |
| InnoPharmax | 793.64M |